Morniflumate
Morniflumate is a nonsteroidal anti-inflammatory drug (NSAID) used primarily for its analgesic, antipyretic, and anti-inflammatory properties. It is the morpholinoethyl ester of niflumic acid, which is a member of the fenamate group of NSAIDs.
Pharmacology[edit]
Morniflumate works by inhibiting the activity of cyclooxygenase (COX), an enzyme involved in the synthesis of prostaglandins. Prostaglandins are lipid compounds that play a key role in the mediation of inflammation, pain, and fever. By reducing the production of prostaglandins, morniflumate helps to alleviate these symptoms.
Indications[edit]
Morniflumate is indicated for the treatment of various conditions, including:
Administration[edit]
Morniflumate is typically administered orally in the form of tablets or capsules. The dosage and duration of treatment depend on the specific condition being treated and the patient's response to the medication.
Side Effects[edit]
Common side effects of morniflumate include:
Serious side effects, although rare, may include:
Contraindications[edit]
Morniflumate is contraindicated in patients with:
- Known hypersensitivity to morniflumate or other NSAIDs
- History of gastrointestinal bleeding or peptic ulcer disease
- Severe hepatic or renal impairment
- Asthma exacerbated by NSAIDs
Interactions[edit]
Morniflumate may interact with other medications, including:
- Anticoagulants
- Antiplatelet drugs
- Other NSAIDs
- Corticosteroids
- Diuretics
See Also[edit]
References[edit]